Hebrew University of Jerusale

Prof. Amiram Goldblum's


School of Pharmacy
Molecular Modeling and Drug Design Group


Cooperations

  1. Prof. Dr. Martin Ruthardt, Head, Laboratory for Tumor Stem Cell Biology Medical Clinic II, Goethe University, Frankfurt/Main Germany

    Subject 1: Designing inhibitors for the myristoyl binding pocket of Abl Other participants: Dr. Yousef Najajreh (Al-Quds University, Palestinian Authority), and Dr.Jamal Mahajneh (Migal Institue, Koryat Shmona, Israel)

    Subject 2: Peptides inhibition of Bcr-Abl oligomerization to prevent CML cell proliferation Other participant: Prof. Yehezkel Barenholtz (Medicine, Hebrew University)

  2. CancerGrid EU consortium, Subjects: Inhibition of RET-kinase, HDAC and HSP90, differential cytotoxicity List of participants
     
  3. Prof. Angelo Carotti, School of Pharmacy, Bari, Italy Subject: Focused libraries of MMP inhibitors
     
  4. Prof. Marta Weinstock-Rosin, Dept. of Pharmacology, Hebrew University School of Pharmacy. Subject: Non-covalent inhibition of acetylcholinesterase
     
  5. Prof. Andrej Bohac, Comenius University Bratislava, Slovakia Subject: Inhibition of VEGFR-2 (KDR)
     
  6. Prof. Alexander Varnek, Univ. of Strasbourg, France Subject: Methods in Chemoinformatics
     
  7. Prof. Alexander Tropsha, Univ. of North Carolina Chapel Hill Subject: Polypharmacological mechanisms of action
     
  8. Prof. Yechezkel (Chezi) Barenholtz, Hebrew University Fac. of Medicine Subject: Role of molecular physical properties in liposome loading and release
     
  9. Prof. David Varon, Hematology Unit, Sharet Cancer Institute, Hadassah Ein Kerem, Jerusalem Subject: Inhibition of ADAMTS-13
     
  10. Angiokem EU COST action, Subject: Inhibition of Angiogenesis
     

 

Last Update : June 15, 2009 | Copyright ©, 2009, The Hebrew University of Jerusalem. All Rights Reserved.